Cap Analogs
m7GpppApG triammonium salt
Quick view. A trinucleotide mRNA 5' cap analogue supplied in triammonium form for research-use in-vitro RNA synthesis. Exact-form composition and the current specification are confirmed by inquiry. A public CAS number is not assigned for this exact form. Catalog target purity: By inquiry. Availability: Inquiry only — contact BX Lab to confirm current availability.
Identifier context
These notes preserve the current catalog identifiers while making their review boundary explicit.
The retained related nucleotide-core identifier is not published as the identifier of the complete triammonium catalog product. Confirm the exact supplied form when requesting a quote.
Core and triammonium formula and molecular-weight values are withheld until an independent exact-form identity binding is available.
Current purity and analytical basis are confirmed by inquiry for the supplied material; no lot-specific BX Lab specification is published on this page.
Product profile
m7GpppApG triammonium salt is classified as cap analogs.
m7GpppApG triammonium salt — Trinucleotide cap analogue material for in-vitro RNA synthesis research.
For m7GpppApG triammonium salt, capping outcome depends on polymerase system, cap-to-NTP ratio, transcript design and purification method.
Names and search terms
Confirmed or normalized name variants
- CAP m7G(5')ppp(5')ApG Ammonium Salt
- m7G(5')ppp(5')ApG triammonium
Useful catalog search terms
- m7G(5')ppp(5')ApG
- Cap Analogs
Physicochemical data
| Counterion form | Triammonium |
|---|---|
| Nucleotide shorthand | m7GpppApG |
| Technical data status | Catalog CAS, core and triammonium composition values, and catalog purity are withheld pending independent exact-form confirmation. |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Product-specific evaluation notes
Potential advantages
- Cap analog selection can influence capping efficiency, orientation and downstream translation-related performance.
Method limitations
- Capping outcome depends on polymerase system, cap-to-NTP ratio, transcript design and purification method.
These points describe m7GpppApG triammonium salt or its named chemical feature. Broader product-family guidance is maintained on the category page.
Related products
ARCA (m2(7,3'-O)GpppG)
Cap Analogs · CAS: 400806-46-4
BX-CA-0002A(5')ppp(5')(2'-OMeA)pG tetraammonium
Cap Analogs · CAS: N/A
BX-CA-0003m7G(UNA)(5')ppp(5')(2'-OMeA)pG triammonium
Cap Analogs · CAS: N/A
BX-CA-0004m7G(5')vppp(5')(2'-OMeA)pG triammonium
Cap Analogs · CAS: 3038327-80-6
BX-CA-0005CAP 6 m7G(LNA)(5')ppp(5')(2'OMeA)pG Triammonium Salt
Cap Analogs · CAS: N/A
BX-CA-0006CAP 7 m7G(HNA)(5')ppp(5')(2'OMeA)pG Ammonium Salt
Cap Analogs · CAS: N/A
Frequently asked questions
Can the package size for m7GpppApG triammonium salt be customized?
Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.
What information should be included in a quote request?
Quote catalog number BX-CA-0024, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not a BX Lab lot specification or product-performance claim.
Technology platforms
Catalog-derived platform membership for navigating related chemistry and verifiable product sets.